Palivizumab is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease (bronchopulmonary dysplasia, premature birth, and hemodynamically significant congenital heart disease).

NON-FDA APPROVED USES

  • Treatment of severe RSV pneumonia in immunocompromised adult patients (limited data).

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease (bronchopulmonary dysplasia, premature birth, and hemodynamically significant congenital heart disease).

NON-FDA APPROVED USES

  • Treatment of severe RSV pneumonia in immunocompromised adult patients (limited data).

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: November 9, 2022